Wave Life Sciences, Inc. (WVE) stock
WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3039% below fair value
$3.13−0.02 (-0.79%)
Close on Nov 13, 2026Market cap $617.33MP/E –Yield –
Wave Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Wave Life Sciences's enterprise value was $170.41M on Nov 11, 2026, against $1.29B a year earlier. Over the last 5 years it ranged from -$33.87M to $2.53B, with a median of $385.81M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $170.41M | -93.3% |
| 2025 | Dec 31, 2025 | $2.53B | +65.9% |
| 2024 | Dec 31, 2024 | $1.52B | +323.4% |
| 2023 | Dec 29, 2023 | $360.07M | -25.9% |
| 2022 | Dec 30, 2022 | $485.89M | +1133.9% |
| 2021 | Dec 31, 2021 | $39.38M | -76.5% |
| 2020 | Dec 31, 2020 | $167.45M | +154.6% |
| 2019 | Dec 31, 2019 | $65.78M | -93.6% |
| 2018 | Dec 31, 2018 | $1.03B | +27.3% |
| 2017 | Dec 29, 2017 | $806.19M | +81.2% |
| 2016 | Dec 30, 2016 | $444.84M | +448.7% |
| 2015 | Dec 31, 2015 | $81.07M | – |
See a number that looks wrong?